Where does Auxibio Therapeutics rank among its competitors?

Auxibio Therapeutics ranks 2067th amongst 2491 active competitors, of which 95 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Biorad Medisys, which secured $47.9M in May, 2024.

Who are the top competitors of Auxibio Therapeutics?

Auxibio Therapeutics' top competitors include Boston Scientific, Abbott and Medtronic. Among them, Biorad Medisys secured the most recent funding round in May, 2024.

Auxibio Therapeutics - 2026 Company Profile & Competitors

Auxibio Therapeutics is an unfunded company. It operates as a Developer of biomedical devices and biotherapeutics, including cell therapy solutions. Auxibio Therapeutics has not raised any funding yet. The company has 2491 active competitors, including 95 funded and 171 that have exited. Its top competitors include companies like Boston Scientific, Abbott and Medtronic.

Company Details

Developer of biomedical devices and biotherapeutics, including cell therapy solutions. The company focuses on creating transformative therapies and devices to address healthcare challenges. It specializes in advancing patient care and outcomes through biomedical innovations. The company is dedicated to developing effective therapeutic solutions tailored for diverse medical needs.

Key Metrics

Stage

Unfunded

Ranked

2067^th among 2491 active competitors

Similar Companies

Boston Scientific & 2507 more

View Auxibio Therapeutics' full profile

Auxibio Therapeutics has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Auxibio Therapeutics include Boston Scientific, Abbott and Medtronic. Here is the list of Top 10 competitors of Auxibio Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Boston Scientific 1979, Marlborough (United States), Public	Wide range of medical devices	-	JANA Partners, Endeavour Vision & 10 others	81/100
2nd	Abbott 1888, Libertyville (United States), Public	Developer of medical devices, generic pharmaceuticals, and nutrition products	-	MSN Laboratories, Digital Pharma Lab & 12 others	76/100
3rd	Medtronic 1949, Minneapolis (United States), Public	Manufacturer of medical devices and technologies for healthcare clinical applications	-	Greyrock Investments, Digital Pharma Lab ... & 26 others	74/100
4th	Becton Dickinson 1897, Franklin Lakes (United States), Public	Manufacturer of medical devices, diagnostic systems, and medication management technology	-	Gershon Capital, Tekla Capital Management ... & 6 others	73/100
5th	Danaher 1969, Washington, DC (United States), Public	R&D company focused on manufacturing dental equipment for multiple therapeutic areas	-	Ventana Capital Management, Bank of America	69/100
6th	Baxter 1931, Deerfield (United States), Acquired	Provides biosciences, medication delivery and renal products	-	Triodos Investment Management, Bregal Sagemount ... & 7 others	68/100
7th	Trivitron 1997, Chennai (India), Series C	Provider of medical technology and devices for healthcare industry needs	$109M	Fidelity Investments, True North & 21 others	68/100
8th	SAGE Therapeutics 1971, Boston (United States), Acquired	Developer of drug candidates for the treatment of rare CNS disorders	$106M	Foresite Capital, Orbimed & 12 others	65/100
9th	HOYA 1941, Shinjuku (Japan), Public	Developer of a wide range of medical devices	-	-	66/100
10th	Biorad Medisys 2007, Pune (India), Series A	Manufacturer of medical devices for orthopaedic, neurovascular, and endovascular procedures	$53.4M	InvAscent, BioMediCon & 5 others	65/100
2067th	Auxibio Therapeutics Unfunded	Developer of biomedical devices and biotherapeutics, including cell therapy solutions	-	-	16/100